MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Variation in Longevity Gene KLOTHO Associates with Measures of Resilience Against Parkinson’s Disease

    N. Luthra, J. Ostrem, D. Dubal (San Francisco, CA, USA)

    Objective: We investigated whether carrying one copy of the protective haplotype “KL-VS” of the longevity gene KLOTHO is associated with better cognitive functioning and/or attenuated…
  • 2017 International Congress

    Event-related potentials and mild cognitive impairment in Parkinson’s disease.

    J. Pagonabarraga, J. Marin-Lahoz, A. Horta, M. Cornella, H. Bejr-Kasem, S. Martinez-Horta, J. Pérez-Pérez, M.Á. Boti, J. Kulisevsky (Barcelona, Spain)

    Objective: To measure N170, P3a/P3b peak amplitudes and latencies in PD with (PD-MCI) and without (PD-NC) mild cognitive impairment and to correlate them with clinical-demographic, neuropsychological and…
  • 2017 International Congress

    Neurodegenerative biomarker abnormality frequency in idiopathic REM sleep behavior disorder

    A. Boeve, S. McCord, P. Timm, D. Sandness, N. Commers, E. Duwell, G. Tabatabai, S. McCarter, M. Junna, M. Lipford, M. Tippmann-Peikert, B. Boeve, M. Silber, E. St. Louis (Rochester, MN, USA)

    Objective: To describe the frequencies of neurodegenerative biomarker abnormalities in the adult Mayo Clinic iRBD prospective registry cohort. Background: The majority of patients with idiopathic…
  • 2017 International Congress

    Parkinson’s disease in untreated Gaucher patients is associated with reduced glucosylsphingosine (Lyso-Gb1) serum levels

    D. Arkadir, T. Dinur, A. Rolfs, A. Zimran (Jerusalem, Israel)

    Objective: To assess the role of glycosphingolipids in increased risk of Parkinson's disease (PD) in patients with Gaucher disease (GD). Background: Patients with GD are…
  • 2017 International Congress

    The therapeutic effect of MANF in the MPTP/MPP+-induced model of Parkinson’s disease

    y. liu (shanghai city, China)

    Objective: To observe therapeutic effect of MANF in the attenuation of neurotoxin MPTP/MPP+-induced model of Parkinson's disease Background: Mesencephalic astrocyte-derived neurotrophic factor (MANF) is a…
  • 2017 International Congress

    Parkinsonian Features in a Cohort of Gaucher’s Disease (GD) Patients and Relatives.

    I. Trezzi, E. Monfrini, G. Buongarzone, E. Cassinerio, I. Motta, F. Nascimbeni, F. Carubbi, N. Bresolin, G. Comi, M. Cappellini, A. Di Fonzo (Milan, Italy)

    Objective: to investigate the prevalence and clinical features of parkinsonism in a cohort of 21 GD patients and their relatives. Background: GD is a lysosomal…
  • 2017 International Congress

    Pure ATXN10 repeat expansion causes Parkinson’s disease

    F. Jimenez Gil, K. McFarland, K. Lee, Y.-C. Tsai, C. Byrne, R. Gopi, N. Huang, J. Langston, T. Clark, T. Ashizawa, B. Schuele (Guadalajara, Jalisco, Mexico)

    Objective: Clinical and genetic characterization of a multigenerational family with spinocerebellar ataxia type 10 (SCA10) and parkinsonism. Background: Pentanucleotide repeat expansions of ATTCT in intron…
  • 2017 International Congress

    Short term effects of bilateral STN DBS on psychiatric profile in Parkinson’s disease

    R. Alugolu, M.B. Kesani, B. Ganji, V. Mudumba, R. Mrudula, R. Borgohain, P. Gaddamanugu (Hyderabad, India)

    Objective: We intend to look into the effects of bilateral STN DBS on Psychiatric profile of Parkinson’s patients. Background: Parkinson’s disease is a well-known degenerative…
  • 2017 International Congress

    Young Onset Parkinson’s Disease (YOPD): A different disease entity?

    H. Chan, Y. Cheung, D. Chau, V. Lo, C. Woo, S. Tse, T. Fung, A. Leung, W. Fong (Hong Kong, Hong Kong)

    Objective: To study the clinical manifestations of YOPD and Late Onset Parkinson’s Disease (LOPD) patients Background: Parkinson’s disease (PD) is a neurodegenerative disease commonly affecting…
  • 2017 International Congress

    Determinants of balance confidence and concern about falling in people with Parkinson’s disease

    L. Almeida, G. Valenca, E. Pinto, J. Oliveira-Filho (Salvador, Brazil)

    Objective: To identify factors that contribute to balance confidence and concern about falling in people with Parkinson’s disease (PD). Background: Reduced balance confidence and greater…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley